Neither IL-17A mRNA Nor IL-17A Protein Are Detectable in Langerhans Cell Histiocytosis Lesions
Open Access
- 1 August 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (8) , 1433-1439
- https://doi.org/10.1038/mt.2011.106
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and UveitisScience Translational Medicine, 2010
- Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans CellsThe Journal of Immunology, 2010
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- Th17 cells in autoimmune demyelinating diseaseSeminars in Immunopathology, 2010
- Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosisPediatric Blood & Cancer, 2009
- Interleukin-17A is not expressed by CD207+ cells in Langerhans cell histiocytosis lesionsNature Medicine, 2009
- Interleukin-17 as a drug target in human diseaseTrends in Pharmacological Sciences, 2009
- Langerin (CD207) Staining in Normal Pediatric Tissues, Reactive LymphNodes, and Childhood Histiocytic DisordersPediatric and Developmental Pathology, 2004
- Langerhans cell histiocytosis: A pathologic combination of oncogenesis and immune dysregulationPediatric Blood & Cancer, 2004
- Langerhans-cell histiocytosis 'insight into DC biology'Trends in Immunology, 2003